Midgard
BD

Beijing Dongfang Baitai Biotechnology Co., Ltd

Beijing, China en.east-bt.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Beijing Dongfang Baitai Biotechnology Co., Ltd. is a biopharmaceutical company in Beijing engaged in the research, development, production, and sales of innovative biological drugs. It works on antibody-based medicines for malignant tumors, diabetes, autoimmune diseases, and other major diseases. The company is located in Beijing Economic-Technological Development Area and operates a research and industrialization platform for antibody therapeutics.

Beijing Dongfang Baitai Biotechnology Co., Ltd is based in Beijing, China, founded in 2011. It lists 10 services, including Antibody drug R&D, Monoclonal antibody development and Bispecific antibody development. It names GMP on its listing.

Services

  • Antibody drug R&D

    Researches innovative antibody therapeutics across the drug discovery and development process.

  • Monoclonal antibody development

    Develops monoclonal antibodies for therapeutic use.

  • Bispecific antibody development

    Develops bispecific antibody drugs for disease treatment.

  • Antibody fusion protein development

    Develops antibody fusion protein drugs.

  • ADC development

    Develops antibody-drug conjugates for therapeutic applications.

  • Antibody humanization

    Uses sequence alignment and structural homology modeling to generate humanized antibodies.

  • High-affinity antibody screening

    Uses phage-display screening to identify high-affinity antibody molecules.

  • Engineered cell line construction

    Builds high-expression engineered cell lines for antibody production and process development.

2 more services
  • Process optimization
  • Quality management

How to order from Beijing Dongfang Baitai Biotechnology Co., Ltd

They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Antibodies
  • Bispecifics
  • Toxicology
  • ADCs
  • Process development
  • Phage-display screening
3 more
  • Antibody humanization
  • Three-dimensional structural homology modeling
  • QbD-based quality management
Scale and capacity
  • 3 × 2000L mammalian cell batch culture and purification production line
  • 30 mu first-phase site
  • More than 100 people team
Therapeutic areas
  • Malignant tumors
  • Diabetes
  • Autoimmune diseases
  • Ophthalmic diseases
  • Respiratory diseases
  • Rheumatoid arthritis
3 more
  • Psoriasis
  • Ankylosing spondylitis
  • Nasopharyngeal cancer

Instruments and platforms

  • Cutting-edge analytical techniques

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Recombinant protein
  • Vaccine
Species and models
Animal disease models

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: China, European Union, and FDA

Details

Founded
2011
Team
More than 100 people
Based in
Beijing, China
Serves
China, international

Similar labs